Skip to main content

Diabetic Ulcer clinical trials at UCSF

3 in progress, 2 open to eligible people

Diabetic Ulcers are sores on the skin that occur in people with diabetes. UCSF is conducting studies to find new ways to help these ulcers heal. In one study, researchers are looking for biomarkers that predict wound healing in people with diabetic foot ulcers. In another study, a biorepository will guide the collection and storage of data from patients enrolled in other diabetic ulcer trials. Join us to help find new treatments.

Showing trials for
  • Adjunct Collection of Additional Biorepository Data From Patients Enrolled in Diabetic Foot Consortium (DFC) Trials

    open to eligible people ages 18 years and up

    The Biorepository will guide the Diabetic Foot Consortium (DFC) activities for collection and storing biosamples and data from participants enrolled in other current and future DFC research studies.

    San Francisco, California and other locations

  • C-myc Biomarker Study for Diabetic Foot Ulcers

    open to eligible people ages 18 years and up

    This is a multi-center observational cohort study of patients with diabetic foot ulcers (DFU) to develop and validate potential tissue-based biomarkers that predict complete wound healing. Eligible and consented participants will begin standard of care treatment after collection of tissue specimens from the wound's edge. An additional tissue specimen is collected at 4 weeks if clinically indicated. Tissues will be tested for c-myc and phosphorylated glucocorticoid receptor (p-GR) levels using validated protocols at a central laboratory. Participants will be followed weekly for up to 12 weeks or until complete wound healing (whichever occurs first). One final assessment 2 weeks after complete wound healing will occur to confirm healing.

    San Francisco, California and other locations

  • DFC 004 Biomarkers for Active Diabetic Foot Ulcers

    Sorry, not currently recruiting here

    This study is a platform study designed to efficiently test multiple biomarkers to identify diabetic foot ulcers (DFUs) with a higher potential for healing versus not healing that ultimately could be applied at the point of care to drive personalized management decisions, and to better inform clinical trials of wound healing interventions

    San Francisco, California and other locations

Our lead scientists for Diabetic Ulcer research studies include .

Last updated: